semaglutide vision blurry Ozempic Lawsuit Our vitreoretinal surgeon explains what

(The STEP 1 trial)

NICE technology appraisal TA875 (2023) recommends Wegovy within a specialist weight management service for adults with a BMI of 35 kg/m or above (or 30 kg/m in certain high-risk groups) and at least one weight-related health condition, for a maximum of two years

Recent evidence highlights the direct and indirect anti-inflammatory properties of GLP-1, suggesting a potential additional therapeutic strategy for patients with inflammatory bowel disease (IBD)

According to study results, oral semaglutide led to a significant reduction in body weight compared to placebo

Compulsive exercise: Links, risks and challenges faced

Given the limited long-term research, individuals considering this diet should exercise caution and consult healthcare professionals to ensure adequate nutrient intake